好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Incidence and trends of Progressive Supranuclear Palsy and Corticobasal Syndrome in Olmsted County: a population based study (1995-2005).
Movement Disorders
P3 - Poster Session 3 (5:30 PM-6:30 PM)
10-003

To explore the incidence and trends of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS) in a population-based incident cohort study in Olmsted County, MN.


Only few studies have investigated the incidence of PSP and CBS in the population due to their rarity.


We used the 1991-2005 population-based incident cohort study of parkinsonisms in Olmsted County, MN defined via the Rochester Epidemiology Project. A movement disorder specialist reviewed all the medical records to confirm the diagnoses.


We identified 21 patients in our cohort; 18/21 (85.7%) were diagnosed with PSP, whereas 3/21 (14.3%) had a clinical diagnosis of CBS. The median age at diagnosis was 78 years (range: 66-88). 13/21 (62.0%) were male. A MRI was performed before the diagnosis in 10 patients (7 PSP and 3 CBD) and all but one showed cortical atrophy consistent with the clinical diagnoses. Two PSP patients underwent autopsy and showed concordance between the clinical and the pathological diagnoses. The combined incidence for PSP and CBS in Olmsted County, MN was 3.1/100,000 (95% CI 1.7, 4.4, P< 0.001); the incidence was higher in men (4.5, 95% CI, 2.0-7.0, P< 0.001) than women (1.8, 95% CI, 0.5-2.9, P< 0.001). CBS incidence was 0.4/100,000 (95% CI 0.0, 0.9, P<0.001); PSP incidence was 2.6/100,000 (95% CI 1.4, 3.8, P<0.001). When combined a significant trend of increasing incidence was observed between 1991-2005 (B=0.69, 95% CI 0.42, 0.96, p<0.001).


The combined incidence for PSP and CBS was 3.1/100,000 in our cohort and was higher in men than women. We observed a relevant increase in the trend of the incidence of both PSP and CBS, which is likely due to advancing imaging technology and improved diagnostic ability among physicians.


Authors/Disclosures
Cole D. Stang
PRESENTER
Mr. Stang has nothing to disclose.
Pierpaolo Turcano, MD (Rush University Medical Center) Dr. Turcano has nothing to disclose.
Subhadeep Gupta No disclosure on file
Keith A. Josephs, Jr., MD, FAAN (Mayo Clinic) Dr. Josephs has nothing to disclose.
James H. Bower, MD, MSc, FAAN (Mayo Clinic) The institution of Dr. Bower has received research support from Abbvie.
J. E. Ahlskog, MD, PhD (Mayo Clinic) Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Bradley F. Boeve, MD, FAAN (Mayo Clinic) Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
David S. Knopman, MD, FAAN (Mayo Clinic) Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Rodolfo Savica, MD, PhD, FAAN (Mayo Clinic) The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.